Malin Parmar

Regional specification of neurosphere cultures derived from subregions of the embryonic telencephalon.

A transplantation study of expanded human embryonic forebrain precursors: evidence for selection of a specific progenitor population.

Phenotypic and molecular identity of cells in the adult subventricular zone. in vivo and after expansion in vitro.

Striatal neuron differentiation from neurosphere-expanded progenitors depends on Gsh2 expression.

Neurogenin2 identifies a transplantable dopamine neuron precursor in the developing ventral mesencephalon.

Retrovirally delivered Islet-1 increases recruitment of Ng2 expressing cells from the postnatal SVZ into the striatum.

In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133.

Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells.

Strengths and limitations of the neurosphere culture system.

Early specification of dopaminergic phenotype during ES cell differentiation.

Reprogramming of neonatal SVZ progenitors by islet-1 and neurogenin-2.

Dopamine neuron precursors within the developing human mesencephalon show radial glial characteristics.

Organization of the human embryonic ventral mesencephalon.

Tracking differentiating neural progenitors in pluripotent cultures using microRNA-regulated lentiviral vectors.

Neural grafting in Parkinson's disease Problems and possibilities.

Direct conversion of human fibroblasts to dopaminergic neurons.

Turning skin into dopamine neurons.

Efficient induction of functional neurons from adult human fibroblasts.

Generation of transplantable striatal projection neurons from human ESCs.

Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment.

Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions.

Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens.

Generating regionalized neuronal cells from pluripotency, a step-by-step protocol.

Generation of induced neurons via direct conversion in vivo.

Human foetal brain tissue as quality control when developing stem cells towards cell replacement therapy for neurological diseases.

The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons.

Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation.

Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain.

Direct neural conversion from human fibroblasts using self-regulating and nonintegrating viral vectors.

Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease.

Monosynaptic Tracing using Modified Rabies Virus Reveals Early and Extensive Circuit Integration of Human Embryonic Stem Cell-Derived Neurons.

In Vivo Reprogramming of Striatal NG2 Glia into Functional Neurons that Integrate into Local Host Circuitry.

Cell-based therapies for Parkinson disease—past insights and future potential.

Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor.

In Vivo Reprogramming for Brain and Spinal Cord Repair.

Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?

DREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 Receptor.

hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation.

Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015.

Plug and Play Brain: Understanding Integration of Transplanted Neurons for Brain Repair.

Small molecules increase direct neural conversion of human fibroblasts.

TRIM28 Controls a Gene Regulatory Network Based on Endogenous Retroviruses in Human Neural Progenitor Cells.

Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.

Single-Cell Analysis Reveals a Close Relationship between Differentiating Dopamine and Subthalamic Nucleus Neuronal Lineages.

Synaptic inputs from stroke-injured brain to grafted human stem cell-derived neurons activated by sensory stimuli.

Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD).

REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways.

Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications.

Direct Reprogramming of Resident NG2 Glia into Neurons with Properties of Fast-Spiking Parvalbumin-Containing Interneurons.

Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation.

Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.

IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.

Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned?

Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era.

Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming.

Towards stem cell based therapies for Parkinson's disease.

Directly Converted Human Fibroblasts Mature to Neurons and Show Long-Term Survival in Adult Rodent Hippocampus.